Citizens & Northern Corp Trevena Inc Transaction History

Citizens & Northern Corp

  • $331 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022
BUY
$0.2 - $0.5 $3,200 - $8,000
16,000 New
16,000 $7,000
Q1 2020

May 08, 2020
SELL
$0.56 - $0.97 $30,408 - $52,671
-54,300 Closed
0 $0
Q2 2017

Aug 11, 2017
BUY
N/A
54,300
54,300 $125,000

About TREVENA INC

TRVN Quotes by TradingView
  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Citizens & Northern Corp Portfolio

Follow Citizens & Northern Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens & Northern Corp, based on Form 13F filings with the SEC.

News

Stay updated on Citizens & Northern Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email